• 1
    Purohit V, Russo D, Coates PM. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. Alcohol 2004; 34: 38.
  • 2
    Lakshman MR. Some novel insights into the pathogenesis of alcoholic steatosis. Alcohol 2004; 34: 4548.
  • 3
    Nagy LE. Molecular aspects of alcohol metabolism: transcription factors involved in early alcohol-induced liver injury. Annu Rev Nutr 2004; 24: 5578.
  • 4
    Crabb DW, Liangpunsakul S. Alcohol and lipid metabolism. J Gastroenterol Hepatol 2006; 21: S56S60.
  • 5
    McClain CJ, Antonow DR, Cohen DA, Shedlofsky S. Zinc metabolism in alcoholic liver disease. Alcohol Clin Exp Res 1986; 10: 582589.
  • 6
    Kiilerich S, Dietrichson O, Loud FB, Naestoft J, Christoffersen P, Juhl E, et al. Zinc depletion in alcoholic liver diseases. Scand J Gastroenterol 1980; 15: 363367.
  • 7
    Bode JC, Hanisch P, Henning H, Koenig W, Richter FW, Bode C. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. HEPATOLOGY 1988; 8: 16051609.
  • 8
    Rodríguez-Moreno F, González-Reimers E, Santolaria-Fernández F, Galindo-Martín L, Hernandez-Torres O, Batista-López N, et al. Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol 1997; 14: 3944.
  • 9
    Giménez A, Caballería J, Parés A, Alié S, Deulofeu R, Andreu H, et al. Influence of dietary zinc on hepatic collagen and prolyl hydroxylase activity in alcoholic rats. HEPATOLOGY 1992; 16: 815819.
  • 10
    Cabré M, Folch J, Giménez A, Matas C, Parés A, Caballería J, et al. Influence of zinc intake on hepatic lipid peroxidation and metallothioneins in alcoholic rats: relationship to collagen synthesis. Int J Vitam Nutr Res 1995; 65: 4550.
  • 11
    Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Kang YJ. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 2005; 166: 16811690.
  • 12
    Kang X, Song Z, McClain CJ, Kang YJ, Zhou Z. Zinc supplementation enhances hepatic regeneration by preserving hepatocyte nuclear factor-a in mice subjected to a long-term alcohol administration. Am J Pathol 2008; 172: 916925.
  • 13
    Zhou Z, Liu J, Song Z, McClain CJ, Kang YJ. Zinc supplementation inhibits hepatic apoptosis in mice subjected to a long-term alcohol exposure. Exp Biol Med 2008; 233: 540548.
  • 14
    Tomita K, Azuma T, Kitamura N, Tamiya G, Ando S, Nagata H, et al. Leptin deficiency enhances sensitivity of rats to alcoholic steatohepatitis through suppression of metallothionein. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1078G1085.
  • 15
    tom Dieck H, Döring F, Fuchs D, Roth HP, Daniel H. Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. J Nutr 2003; 133: 10041010.
  • 16
    tom Dieck H, Döring F, Roth HP, Daniel H. Transcriptome and proteome analysis identifies the pathways that increase hepatic lipid accumulation in zinc-deficient rats. J Nutr 2005; 135: 199205.
  • 17
    Yousef MI, El-Hendy HA, El-Demerdash FM, Elagamy EI. Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 2002; 175: 223234.
  • 18
    Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001; 21: 13931403.
  • 19
    Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 2004; 34: 3538.
  • 20
    Sozio M, Crabb DW. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab 2008; 295: E10E16.
  • 21
    Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 1998; 273: 56785684.
  • 22
    Tietge UJF, Bakillah A, Maugeais C, Tsukamoto K, Hussain M, Rader DJ. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res 1999; 40: 21342139.
  • 23
    Webster KA, Prentice H, Bishopric NH. Oxidation of zinc finger transcription factors: physiological consequences. Antioxid Redox Signal 2001; 3: 535548.
  • 24
    Wilcox DE, Schenk AD, Feldman BM, Xu Y. Oxidation of zinc-binding cysteine residues in transcription factor proteins. Antioxid Redox Signal 2001; 3: 549564.
  • 25
    Conte D, Narindrasorasak S, Sarkar B. In vivo and in vitro iron-replaced zinc finger generates free radicals and causes DNA damage. J Biol Chem 1996; 271: 51255130.
  • 26
    Sarkar B. Metal replacement in DNA-binding zinc finger proteins and its relevance to mutagenicity and carcinogenicity through free radical generation. Nutrition 1995; 11: 646S649S.
  • 27
    Powell SR. The antioxidant properties of zinc. J Nutr 2000; 130: 1447S1454S.
  • 28
    Hao Q, Maret W. Aldehydes release zinc from proteins. A pathway from oxidative stress/lipid peroxidation to cellular functions of zinc. FEBS J 2006; 273: 43004310.
  • 29
    Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci 1995; 56: 307317.
  • 30
    Nanji AA, Dannenberg AJ, Jokelainen K, Bass NM. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPAR alpha)-regulated genes and is ameliorated by PPAR alpha activation. J Pharmacol Exp Ther 2004; 310: 417424.
  • 31
    Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in alcohol-fed mice. J Biol Chem 2003; 278: 2799728004.
  • 32
    Watt AJ, Garrison WD, Duncan SA. HNF4: a central regulator of hepatocyte differentiation and function. HEPATOLOGY 2003; 37: 12491253.
  • 33
    Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 13781381.
  • 34
    Lakshmanan MR, Felver ME, Veech RL. Alcohol and very low density lipoprotein synthesis and secretion by isolated hepatocytes. Alcohol Clin Exp Res 1980; 4: 361365.
  • 35
    Venkatesan S, Ward RJ, Peters TJ. Effect of chronic alcohol feeding on the hepatic secretion of very-low-density lipoproteins. Biochim Biophys Acta 1988; 960: 6166.
  • 36
    Guzman M, Castro J. Zonal heterogeneity of the effects of chronic alcohol feeding on hepatic fatty acid metabolism. HEPATOLOGY 1990; 12: 10981105.
  • 37
    Tomita K, Azuma T, Kitamura N, Nishida J, Tamiya G, Oka A, et al. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 2004; 126: 873885.
  • 38
    Kang L, Chen X, Sebastian BM, Pratt BT, Bederman IR, Alexander JC, et al. Chronic alcohol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic alcohol contributes to increased triglyceride degradation. J Biol Chem 2007; 282: 2846528473.